SCHEMBL536309

SCHEMBL536309

O=c1oc2cc(Cl)ccc2n1CC#CI

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.47
LMNA P02545 2/20 0.47
CYP3A4 P08684 1/20 0.47
HPGD P15428 1/20 0.47
HSD17B10 Q99714 1/20 0.47
PIK3CB P42338 1/20 0.47
IDO1 P14902 5/20 0.47
KMT2A Q03164 1/20 0.46
MAPT P10636 3/20 0.44
NPC1 O15118 1/20 0.44
ALDH1A1 P00352 1/20 0.44
ALPG P10696 1/20 0.44
RAB9A P51151 1/20 0.44
KMO O15229 1/20 0.43
NOS3 P29474 2/20 0.42
NOS1 P29475 2/20 0.42
NOS2 P35228 2/20 0.42
TP53 P04637 2/20 0.42
POLB P06746 1/20 0.42
TMEM97 Q5BJF2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9715935 0.89 IDO1 (0.61) IDO1KMONOS3NOS1NOS2
SCHEMBL9365104 0.86 TDP1 (0.47) TDP1LMNACYP3A4HPGDHSD17B10
SCHEMBL9716002 0.83 MIF (0.44) IDO1KMT2ANPC1POLBMIF
SCHEMBL9716052 0.83 MIF (0.57) LMNAKMT2AALDH1A1RAB9APOLB
SCHEMBL9715990 0.83 NPC1 (0.57) LMNAHPGDKMT2ANPC1ALDH1A1
SCHEMBL9715996 0.82 KMO (0.54) IDO1KMT2AALDH1A1KMONOS3
SCHEMBL22802595 0.82 TDP1 (0.49) TDP1LMNACYP3A4HPGDHSD17B10
SCHEMBL9716010 0.80 MET (0.51) LMNAHPGDHSD17B10KMT2AMAPT
SCHEMBL9715963 0.80 KMO (0.46) LMNACYP3A4HPGDHSD17B10KMT2A
SCHEMBL536696 0.79 MAPK1 (0.62) LMNAHPGDIDO1ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240215572-A1 ANTIMICROBIAL PARTICLE DISPERSION MITSUBISHI PENCIL COMPANY, LIMITED (JP) 2024-07-04 US claimed
US-20170215421-A1 BIOCIDE AGENTS LANXESS DEUTSCHLAND GMBH (DE) 2017-08-03 US claimed
EP-2779830-B1 STABILIZATION OF COMPOUNDS CONTAINING IODINE HAVING POLYMERS COMPRISING NITROGEN LANXESS DEUTSCHLAND GMBH (DE) 2017-05-17 EP claimed
US-9585384-B2 Stabilization of compounds comprising iodine LANXESS DEUTSCHLAND GMBH (DE) 2017-03-07 US claimed
EP-3125688-A1 BIOCIDE AGENTS LANXESS Deutschland GmbH (DE) 2017-02-08 EP claimed
US-20160360753-A1 BIOCIDIC MICROCAPSULES LANXESS DEUTSCHLAND GMBH (DE) 2016-12-15 US claimed
US-9326502-B2 Stabilization of compounds containing iodine having polymers comprising nitrogen LANXESS DEUTSCHLAND GMBH (DE) 2016-05-03 US claimed
US-9328065-B2 Nitrogen-containing inorganic carrier materials LANXESS DEUTSCHLAND GMBH (DE) 2016-05-03 US claimed
WO-2015150430-A1 BIOCIDE AGENTS LANXESS DEUTSCHLAND GMBH (DE) 2015-10-08 WO claimed
EP-2926659-A1 Biocidal agent LANXESS Deutschland GmbH (DE) 2015-10-07 EP claimed
EP-2462805-A1 Formulations containing stabilised compounds containing iodine LANXESS Deutschland GmbH (DE) 2012-06-13 EP claimed
EP-2440044-A2 INORGANIC CARRIER MATERIALS CONTAINING NITROGEN Lanxess Deutschland GmbH (DE) 2012-04-18 EP claimed
US-20110217348-A1 TREATED TEXTILE MATERIAL FOR USE IN AQUATIC ENVIRONMENTS BASF SE (DE) 2011-09-08 US claimed
EP-2352876-A1 TREATED TEXTILE MATERIAL FOR USE IN AQUATIC ENVIRONMENTS BASF SE (DE) 2011-08-10 EP claimed
US-7943644-B2 Stabilization of iodine-containing biocides by means of special azole compounds LANXESS DEUTSCHLAND GMBH (DE) 2011-05-17 US claimed
US-20110009268-A1 IPBC-CONTAINING COACERVATES LANXESS DEUTSCHLAND GMBH (DE) 2011-01-13 US claimed
WO-2010142795-A2 INORGANIC CARRIER MATERIALS CONTAINING NITROGEN LANXESS DEUTSCHLAND GMBH (DE) 2010-12-16 WO claimed
WO-2010052153-A1 TREATED TEXTILE MATERIAL FOR USE IN AQUATIC ENVIRONMENTS BASF SE (DE) 2010-05-14 WO claimed
EP-1981629-A1 IPBC-CONTAINING COACERVATES Lanxess Deutschland GmbH (DE) 2008-10-22 EP claimed
WO-2007087994-A1 IPBC-CONTAINING COACERVATES LANXESS DEUTSCHLAND GMBH (DE) 2007-08-09 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240215572-A1 ANTIMICROBIAL PARTICLE DISPERSION Q6ZSR9, PAM, ACMSD TDP1 2381/4885LMNA 4330/4885CYP3A4 648/4885
US-20110217348-A1 TREATED TEXTILE MATERIAL FOR USE IN AQUATIC ENVIRONMENTS C9, ADORA2B, C5 TDP1 1368/4885LMNA 754/4885CYP3A4 1171/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.